Skip to main content
Theodoros Michelakos, MD, General Surgery, Chicago, IL

Theodoros Michelakos MD

Endocrine, Hepatobiliary Surgery


Physician

Join to View Full Profile
  • 5841 S Maryland Ave RM O217Chicago, IL 60637

  • Phone+1 773-896-6160

Dr. Michelakos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Theodoros Michelakos is a Chicago-based general surgeon with subspecialties in endocrine and hepatobiliary surgery. He completed his surgical residency at Massachusetts General Hospital from 2017 to 2024, after graduating in 2013 from the University of Athens. Dr. Michelakos has contributed to the field through multiple publications, including research on pancreatic ductal adenocarcinoma, pancreatic neuroendocrine tumors, and the development of a natural language processing algorithm for pancreatic neoplasms. His work is published in noted medical journals such as Cancer Letters, Annals of Surgery, Pancreas, and Histopathology, and has been cited in other research, demonstrating recognition by peers in his field.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Surgery, 2017 - 2024
  • University of Athens
    University of AthensClass of 2013

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2024 - 2026
  • MA State Medical License
    MA State Medical License 2017 - 2024
  • Surgery
    American Board of Surgery Surgery

Publications & Presentations

PubMed

Journal Articles

  • Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?  
    Theodoros Michelakos, Dimitrios Xourafas, David Berger, James F Markmann, Cristina R Ferrone, Motaz Qadan, Kenneth K Tanabe, Joel T Adler, Nahel Elias, Heidi Yeh, Madh..., Journal of gastrointestinal surgery

Press Mentions

  • Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
    Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant TherapyJanuary 26th, 2021

Other Languages

  • French, Greek

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: